Thursday, May 14, 2026
ADVT 
National

'Troubled' Eby seeks CSIS interference briefing

Darpan News Desk The Canadian Press, 17 Mar, 2023 12:42 PM
  • 'Troubled' Eby seeks CSIS interference briefing

VANCOUVER - British Columbia Premier David Eby says he's "very troubled" by allegations of Chinese interference in Vancouver's municipal elections last year and he's asked Canada's intelligence agency for a briefing.

Eby says Canadians deserve a "thorough and independent investigation" into the claims reported in the Globe and Mail newspaper this week that China's consulate in Vancouver meddled in the municipal polls by using diaspora community groups and grooming certain candidates.

The premier says he's asked for a "full briefing" by the Canadian Security Intelligence Service but he hasn't received it yet.

The newspaper report cites CSIS documents, but Eby says he's not in a position to comment on their credibility.

The report prompted Vancouver Mayor Ken Sim to say on Thursday that he was disgusted by its "insinuations," and he wouldn't be part of the conversation if he was Caucasian.

Eby says the majority of tools to fight international interference are in federal hands, but he needs to know if there's any way for B.C. to "close any gaps" that the province may have available to it.

He says that, for example, Elections BC has already brought forward recommendations to combat misinformation.

"We're always looking for ways to make sure our elections are free and fair," Eby said at a news conference in Prince Rupert.

This week's newspaper report says the CSIS documents do not name the consulate's favoured mayoral and council contenders, but it wanted the incumbent Kennedy Stewart to lose.

Sim, Vancouver's first Canadian mayor of Chinese descent, defeated Stewart by more than 36,000 votes.

MORE National ARTICLES

Twitter board to evaluate Musk's 'unsolicited, non-binding' $43B offer

Twitter board to evaluate Musk's 'unsolicited, non-binding' $43B offer
Earlier in the day, Musk made an offer to buy 100 per cent of Twitter at $54.20 per share, a 54 per cent premium over the closing price of Twitter on January 28, 2022, the trading day before Musk began investing in the company. This is a 38 per cent premium over the closing price of Twitter on April 1, 2022, the trading day before Musk's investment in Twitter was publicly announced.

Twitter board to evaluate Musk's 'unsolicited, non-binding' $43B offer

Feds to target need with housing cash, Hussen says

Feds to target need with housing cash, Hussen says
Housing Minister Ahmed Hussen said the budget's plan to double housing starts over the next decade will aim to incentivize the construction of units needed by seniors who are downsizing, for example, as well as newcomer families.

Feds to target need with housing cash, Hussen says

B.C. fires, floods add uncertainty to spring thaw

B.C. fires, floods add uncertainty to spring thaw
Major wildfires, droughts and mudslides last year dramatically altered the landscape, raising questions about the river's ability to handle the spring thaw, or freshet.

B.C. fires, floods add uncertainty to spring thaw

Confirmed outbreak of avian flu in B.C.

Confirmed outbreak of avian flu in B.C.
She says all poultry producers, including backyard poultry owners, are advised to increase their biosecurity practices and carefully monitor their flocks for any sign of illness.

Confirmed outbreak of avian flu in B.C.

Singh demands Indian PM stop anti-Muslim hate

Singh demands Indian PM stop anti-Muslim hate
In an outspoken intervention into Indian politics, Singh says he is deeply concerned by images, videos and targeted threats of violence against the country's Muslim community.    

Singh demands Indian PM stop anti-Muslim hate

Health Canada approves COVID-19 prevention drug

Health Canada approves COVID-19 prevention drug
The drug, named Evusheld, is intended for people who cannot receive a typical vaccine or for whom vaccines alone won't provide enough immunity. AstraZeneca says the drug is not a substitute for vaccination against COVID-19 for most people.    

Health Canada approves COVID-19 prevention drug